← Open Payments lookup

SCOTT WATKINS: Open Payments

NPI 1760950604 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,520 in 85 payments from 13 companies in 2025. Trend: 2023 $3,696 · 2024 $1,811 · 2025 $2,520

Food & beverage: $2,515Education: $5
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.12$449
ABBVIE INC.12$368
Otsuka America Pharmaceutical, Inc.10$342
Teva Pharmaceuticals USA, Inc.8$286
Vanda Pharmaceuticals Inc.12$245
Supernus Pharmaceuticals, Inc.8$186
Neurocrine BioSciences, Inc.3$180
Janssen Pharmaceuticals, Inc4$161
Alkermes, Inc.7$152
Corium, LLC5$89

Products named: VRAYLAR, COBENFY, FANAPT, Qelbree, INGREZZA, REXULTI, INVEGA SUSTENNA, UZEDY.

Industry payments across ID — which companies pay providers there.